GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity.

ABSTRACT:

SUBMITTER: Wang L 

PROVIDER: S-EPMC10704339 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature